Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

DGE’s 2nd Clinical Trial Agreements Conference to Negotiate Budgetary Restraints, Reduce Risks, and More in an Evolving Landscape

Date: September 16-17, 2021 Online Livestream Event – Locations will vary Dynamic Global Events (“DGE”) invites biopharma and medical device industry professionals to join them online September 16-17, 2021, for the 2nd Clinical Trial Agreements Conference. DGE’s first event was held online earlier this year and was focused greatly on the COVID-19 pandemic, the confidentiality […]

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Files Patent Applications to Support Research Phase Programs, Strengthen IP Portfolio

Company’s nonprovisional patent application includes claims to compositions, methods to support certain elements of preclinical and research programs Two international patent applications will grant Cybin the right to file future national applications into treaty member jurisdictions Cybin portfolio consists of 14 patent filings, 50-plus proprietary molecules, 50-plus preclinical studies and 4 active drug programs Cybin […]

AmpliTech Group Inc. (NASDAQ: AMPG) Poised for Anticipated Growth in RF Communications Tech Component Market

Radio frequency (“RF”) technology designer and developer AmpliTech Group is leveraging this year’s Nasdaq uplisting and Russell Microcap Index placement to increase its market visibility AmpliTech builds and markets communications technology products for the satellite communications, space, telecommunications (5G/6G) and military defense markets Markets analysts forecast continued growth over the next five years in the […]

InMed Pharmaceuticals Inc. (NASDAQ: INM) Presents CBN-Based Treatment for Glaucoma at H.C. Wainwright Ophthalmology Virtual Conference

The presentation highlighted the company’s INM-088 cannabinol topical eye drop to treat glaucoma InMed’s IntegraSyn is being used to help the company develop synthetic bioidentical rare cannabinoids in the lab, as most are only found in trace amounts in cannabis plants In addition to INM-088 for glaucoma, the company is currently working on CBN-based INM-755 […]

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Signs Alliance to Evaluate Potential Production of Isotopes for Emerging Cancer Therapeutics

UUUU, RadTran to study the recovery of thorium, radium, from existing rare earth carbonate and uranium process streams The alliance has the potential to develop commercial technologies and sources of isotopes needed for a new domestic medical supply chain Partnership aims to alleviate major bottleneck in the targeted alpha therapy market Due to its highly […]

 

From Our Blog

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Reports New Gold Discovery at Bartec, Expanding Swanson Deposit Potential in Abitibi

October 6, 2026

Disseminated on behalf of LaFleur Minerals Inc. and may include paid advertising. BARTEC GOLD DISCOVERY Canada-based gold explorer LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced on October 5,2026 that the company has recently extended gold mineralization beyond its main Swanson Gold Deposit.  Recent drill results include a new gold discovery at its Bartec […]

Rotate your device 90° to view site.